Life-long cardiorespiratory consequences of early life stress on estrogen actions in female rats.
Key claim: Early-life stress disrupts estrogen-dependent neural signaling in female rats, interacting synergistically with aging and ovarian decline to increase sleep apnea, hypertension, and metabolic vulnerability.
Abstract
Early-life adversity increases risk for disease with sex-specific effects on brain development. While the association between early-life stress and neuropsychiatric disorders is well established, its impact on respiratory health is poorly documented, particularly in females. Here, we review recent studies using neonatal maternal separation (NMS) to examine the long-term consequences of early-life stress on cardiorespiratory function in females. Panic disorder (PD) is an anxiety disorder that is ⁓2 times more prevalent in women. The respiratory subtype is characterised by an exaggerated ventilatory response to CO. NMS augmented the response to 5% COof adult female rats; this effect was most pronounced during proestrus and absent in males. Orexin (ORX) neurons potentiate the COresponse and are normally inhibited by 17β-estradiol (E2). Electrophysiological measurements showed that in control females, excitatory postsynaptic current frequency varied inversely with E2 levels. However, NMS disrupted this E2-mediated inhibition, particularly during proestrus, implicating impaired estrogen action in PD-related respiratory dysfunction. Age-related ovarian decline increases the risk of sleep apnea and associated comorbidities. Whereas apnea frequency decreased with age in control females, 1 year-old NMS females exhibited a 75% higher apnea index than age-matched controls, together with greater adiposity and hypertension. Arterial pressure was inversely correlated with circulating E2 levels only in NMS females, indicating heightened vulnerability to age-related estrogen decline. Although physiological fluctuations in E2 levels exert modest effects in healthy females, we propose that early-life stress persistently alters responsiveness to E2 and acts synergistically with ageing to increase cardiovascular vulnerability throughout the female lifespan.
Why this matters
This review of female-rat evidence [expert-opinion] frames later-life cardiorespiratory and metabolic vulnerability as an interaction between developmental stress, altered estrogen sensitivity, and ovarian decline, rather than estrogen loss alone. Its mechanistic synthesis does not establish the corresponding causal pathway in humans or demonstrate that estrogen treatment reverses stress-associated vulnerability [expert-opinion; preclinical synthesis only].